
No. of Pages: 84 | Report Code: TIPRE00025040 | Category: Life Sciences
No. of Pages: 84 | Report Code: TIPRE00025040 | Category: Life Sciences
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights - Malaria
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Malaria Treatment Market - Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Malaria
4.1.2 Rising Initiatives to Raise Awareness about Malaria
4.2 Market Restraints
4.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
4.3 Market Opportunities
4.3.1 Growing Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Extending Pipeline of New Drugs and Vaccines
4.5 Impact Analysis
5. Malaria Treatment Market - North America Market Analysis
5.1 North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030
6. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment
6.1 Overview
6.2 North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
6.3 Vaccines
6.3.1 Overview
6.3.2 Vaccines Market Revenue and Forecast to 2030 (US$ Mn)
6.4 Generic Drugs
6.4.1 Overview
6.4.2 Generic Drugs Market Revenue and Forecast to 2030 (US$ Mn)
6.5 Originators
6.5.1 Overview
6.5.2 Originators Market Revenue and Forecast to 2030 (US$ Mn)
6.6 Others
6.6.1 Overview
6.6.2 Others Market Revenue and Forecast to 2030 (US$ Mn)
7. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration
7.1 Overview
7.2 North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Parenteral
7.4.1 Overview
7.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Direct Tender
8.3.1 Overview
8.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Hospital Pharmacies
8.4.1 Overview
8.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
8.5 Retail Pharmacies
8.5.1 Overview
8.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
8.6 Online Pharmacies
8.6.1 Overview
8.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Malaria Treatment Market - Country Analysis
9.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
9.1.1 Overview
9.1.1.1 North America: Malaria Treatment Market, by Country
9.1.1.2 US
9.1.1.3 Overview
9.1.1.3.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 US: Malaria Treatment Market, by Treatment
9.1.1.3.3 US: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.3.4 US: Malaria Treatment Market, by Distribution Channel
9.1.1.3.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.3.4.2 US: Malaria Treatment Market, by Retail Pharmacies
9.1.1.4 Canada
9.1.1.5 Overview
9.1.1.5.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.2 Canada: Malaria Treatment Market, by Treatment
9.1.1.5.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.5.4 Canada: Malaria Treatment Market, by Distribution Channel
9.1.1.5.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.5.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
9.1.1.6 Mexico
9.1.1.7 Overview
9.1.1.7.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.2 Mexico: Malaria Treatment Market, by Treatment
9.1.1.7.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
9.1.1.7.4 Mexico: Malaria Treatment Market, by Distribution Channel
9.1.1.7.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
9.1.1.7.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10. Malaria Treatment Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Malaria Treatment Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Cipla Ltd
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sun Pharmaceutical Industries Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Pfizer Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Service
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 AdvaCare Pharma USA LLC
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 VLP Therapeutics LLC
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Lupin Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. Malaria Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
Table 5. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 6. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 7. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 8. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 9. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 10. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 11. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 12. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 14. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 15. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
Table 16. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
Table 17. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 18. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
Table 19. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
Table 20. Recent Inorganic Growth Strategies in the Malaria Treatment Market
Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
Table 22. Glossary of Terms, Malaria Treatment Market
List of Figures
Figure 1. Malaria Treatment Market - Key Industry Dynamics
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Malaria Treatment Market Revenue (US$ million), 2022 - 2030
Figure 4. North America Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 5. Vaccines Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 6. Generic Drugs Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 7. Originators Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 8. Others Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 9. North America Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 10. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 13. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Malaria Treatment Market, By Country, 2022 ($Mn)
Figure 19. North America: Malaria Treatment Market, By Key Countries, 2022 and 2030 (%)
Figure 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Growth Strategies in the Malaria Treatment Market
1. Cipla Ltd
2. Sun Pharmaceutical Industries Ltd
3. Sanofi SA
4. GSK Plc
5. Novartis AG
6. Pfizer Inc
7. AdvaCare Pharma USA LLC
8. VLP Therapeutics LLC
9. Lupin Ltd